XML 22 R13.htm IDEA: XBRL DOCUMENT
v3.22.4

Note G - Economic Dependency | 6 Months Ended
--- | ---
Dec. 31, 2022
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] | G. Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in (i) sales to these customers, (ii) the growth rate of sales to these customers, or (iii) these customers’ ability to make payments when due, each individually could have a material adverse impact on our net sales and net income. Net sales to any one customer representing 10% or more of the respective period's consolidated net sales were as follows (in thousands):
|  | Three Months Ended December 31, |  |  | Six Months Ended December 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Customer 1 |  | $ | 15,982 |  |  | $ | 4,773 |  |  | $ | 30,987 |  |  | $ | 9,121 |
Customer 2 |  |  | 14,112 |  |  |  | 12,966 |  |  |  | 29,265 |  |  |  | 26,264 |
Customer 3 |  |  | 4,503 |  |  |  | 8,595 |  |  |  | 10,831 |  |  |  | 15,988 |
|  | $ | 34,597 |  |  | $ | 26,334 |  |  | $ | 71,083 |  |  | $ | 51,373 |
Accounts receivable from these customers totaled $7.0 million at December 31, 2022 and $10.7 million at June 30, 2022. We buy certain products, including beta-alanine, from a limited number of raw material suppliers who meet our quality standards. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one supplier representing 10% or more of the respective period’s total raw material purchases were as follows (dollars in thousands):
|  | Three Months Ended December 31, |  |  | Six Months Ended December 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Supplier 1 |  | $ | 3,961 |  |  | $ | 4,485 |  |  | $ | 6,793 |  |  | $ | 7,854 |

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI https://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration